Wishing you all the joys of the season! 
Middle East & Africa Microcarriers Market Forecast to 2030
Middle East & Africa Microcarriers Market Forecast to 2030 – Regional Analysis – by Product (Media & Reagents and Microcarrier Beads), Equipment (Bioreactors, Culture Vessels, and Others), Application (Biopharmaceutical Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Need for Cell Therapies with Rising Incidence of Cancer and Infectious Diseases Fuel Middle East & Africa Microcarriers Market
World Health Organization (WHO) states that the global burden of cancer is estimated to rise to 27.5 million new cases and 16.3 million mortalities by 2040. According to World Health Organization (WHO) tuberculosis (TB) is the 13th top cause of death globally and the second leading infectious disease after COVID-19. According to the WHO, there were 1.5 million deaths caused by TB in 2020 (including 214,000 people affected by HIV). In 2020, WHO projected that 10 million people had TB globally, including 1.1 million children, 3.3 million women, and 5.6 million men. TB is present in all age groups and countries. For instance, lung cancer is among one of the main causes of mortality across the world. Lung cancer screening is a critical component of cancer prevention approaches. The prognosis of lung cancer patients is better when the disease is diagnosed early, so people at high risk of lung cancer are prompted to undergo routine check-ups to detect the formation of cancerous growth in their lungs. The prevalence of lung cancer is extremely high in these nations and is expected to keep rising soon. Furthermore, infectious diseases are caused by infectious agents, such as viruses, bacteria, parasites, fungi, and toxic products. HIV is a major public health issue across the world. According to The Joint United Nations Programme on HIVAIDS (UNAIDS), ~ 37.7 million people had HIV in 2020 globally. Out of these, 1.7 million were children aged 0-14 years, and 36 million were adults. Also, more than half (53%) were girls and women. 1.5 million new HIV cases were reported in 2020 globally. Similarly, hepatitis is inflammation of the liver caused by a viral infection. The five main strains of hepatitis viruses are A, B, C, D, and E. According to World Health Organization (WHO), around 58 million people across the globe have chronic hepatitis C virus infection, and ~1.5 million new infections occur every year. The increasing incidence of diseases where cell therapy can be effectively applied, such as cancers, urinary problems, autoimmune diseases, and infectious diseases, is associated with the growth of the microcarriers market. Microcarriers are tiny spheres or particles (typically 90-300 µm in diameter) used for culturing adherent cells in stirred-tank bioreactors. With the growing incidence of cancer and various infectious diseases, the need for proper medication and vaccines arises, which favours the microcarriers market growth.
Middle East & Africa Microcarriers Market Overview
The microcarriers market in the Middle East & Africa is sub segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East and Africa. The market is driven by factors such as extensive research projects undertaken by several research institutes, and the availability of infrastructure, the flourishing biotechnology sector, and facilities for research in the UAE and Saudi Arabia. Further, a huge population base, increasing cases of infectious diseases, growing research studies, and upgrading healthcare facilities help propel the microcarriers market growth across the region. Saudi Arabia is a G20 member that falls under the world’s 20 major economies. The Saudi economy accounts for ~38% of the total GDP of the Middle East. Over the past half-century, Saudi Arabia has been the third fastest-growing economy in the world. Research and technology are significantly governed by an increasing number of research projects undertaken by institutes such as King Abdullah University of Science and Technology. The healthcare system in the country is rapidly developing with many international companies appointing their medical and research teams in the country. In September 2022, Gilead established a fully functional cell therapy business unit and CAR T-cell therapy operations in Saudi Arabia. Gilead and Kite Middle East launched the “Saudi Arabia’s Vision 2030” in which Kite had selected Saudi Arabia as the first location for Middle East operations. The vision aims to establish a fully functional oncologycell therapy business unit in line with international best-in-class protocols for cancer treatment.
Middle East & Africa Microcarriers Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa Microcarriers Market Segmentation
The Middle East & Africa microcarriers market is segmented into product, equipment, application, end user, and country.
Based on product, the Middle East & Africa microcarriers market is bifurcated into microcarriers beads and media & reagents. The microcarriers beads segment held a larger share of the Middle East & Africa microcarriers market in 2022.
In terms of equipment, the Middle East & Africa microcarriers market is segmented into bioreactors, culture vessels, and others. The bioreactors segment held the largest share of the Middle East & Africa microcarriers market in 2022.
Based on application, the Middle East & Africa microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other. The biopharmaceutical production segment held the largest share of the Middle East & Africa microcarriers market in 2022. Further, biopharmaceutical production segment is categorized into therapeutic protein production and vaccine production.
Based on end user, the Middle East & Africa microcarriers market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, and academic & research institutes. The pharmaceutical & biotechnology companies segment held the largest share of the Middle East & Africa microcarriers market in 2022.
Based on country, the Middle East & Africa microcarriers market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa microcarriers market in 2022.
Bio-Rad Laboratories Inc, Sartorius AG, Danaher Corp, Eppendorf SE, Asahi Kasei Corp, and Polysciences Inc are some of the leading companies operating in the Middle East & Africa microcarriers market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team research, the Middle East & Africa microcarriers market was valued at US$ 37.07 million in 2022 and is expected to reach US$ 88.59 million by 2030, registering a CAGR of 11.5% from 2022 to 2030. Automation of cell and gene therapy manufacturing services and increasing popularity of outsourcing cell and gene therapy manufacturing are among the critical factors attributed to the Middle East & Africa microcarriers market expansion.
Incorporating automation in cell and gene therapy manufacturing would lead to a reduced risk of contamination, improved consistency, and decreased cost of production. Lonza Cocoon and the CliniMACS Prodigy system from Miltenyi are a few of the devices available in the market that have been designed to enable the automation of most sequential unit operations for a CAR-T process within a single system. The rising demand for cell and gene therapies has shifted production from a small-volume process to a large-volume process worldwide. The progress of cell and gene therapy from an academic and clinical setting to mass production and commercialization further propels the demand for automation in commercial manufacturing. Thus, automation is emerging as a new trend in the microcarriers market.
On the contrary, high cost of biologics and cell-based therapies hampers the Middle East & Africa microcarriers market.
Based on product, the Middle East & Africa microcarriers market is bifurcated into microcarriers beads and media & reagents. The microcarriers beads segment held 66.9% share of Middle East & Africa microcarriers market in 2022, amassing US$ 24.79 million. It is projected to garner US$ 60.37 million by 2030 to expand at 11.8% CAGR during 2022-2030.
In terms of equipment, the Middle East & Africa microcarriers market is categorized into bioreactors, culture vessels, and others. The bioreactors segment held 64.8% share of Middle East & Africa microcarriers market in 2022, amassing US$ 24.03 million. It is projected to garner US$ 58.59 million by 2030 to expand at 11.8% CAGR during 2022-2030.
Based on application, the Middle East & Africa microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other. The biopharmaceutical production beads segment held 52.1% share of Middle East & Africa microcarriers market in 2022, amassing US$ 19.30 million. It is projected to garner US$ 47.86 million by 2030 to expand at 12.0% CAGR during 2022-2030. Further, biopharmaceutical production segment is categorized into therapeutic protein production and vaccine production.
Based on end user, the Middle East & Africa microcarriers market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, and academic & research institutes. The pharmaceutical & biotechnology companies segment held 55.6% share of Middle East & Africa microcarriers market in 2022, amassing US$ 20.61 million. It is projected to garner US$ 50.46 million by 2030 to expand at 11.8% CAGR during 2022-2030.
By country, the Middle East & Africa microcarriers market has been categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 36.9% share of Middle East & Africa microcarriers market in 2022. It was assessed at US$ 13.67 million in 2022 and is likely to hit US$ 33.81 million by 2030, exhibiting a CAGR of 12.0% during 2022-2030.
Key players operating in the Middle East & Africa microcarriers market are Bio-Rad Laboratories Inc, Sartorius AG, Danaher Corp, Eppendorf SE, Asahi Kasei Corp, and Polysciences Inc, among others.
In May 2022, Saint-Gobain Life Sciences released beadMATRIX for mesenchymal stromal cells (MSCs). beadMATRIX are ready-to-use, pre-coated microcarriers free of animal components that are used to cultivate superior MSCs in vitro. Shaker bags, stirred tanks, vertical wheel bioreactors, and shaker flasks are the perfect environments for beadMATRIX.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa microcarriers market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Microcarriers Market – Key Industry Dynamics
4.1 Key Market Drivers:
4.1.1 Need for Cell Therapies with Rising Incidence of Cancer and Infectious Diseases
4.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
4.1.3 Surge in Adoption of Regenerative Medicine
4.2 Market Restraints
4.2.1 High Cost of Biologics and Cell-based Therapies
4.3 Market Opportunities
4.3.1 Strategic Initiatives and Innovative Products by Microcarrier Manufacturers
4.4 Future Trends
4.4.1 Automation of Cell and Gene Therapy Manufacturing Services
4.5 Impact Analysis
5. Microcarriers Market – Middle East & Africa Market Analysis
5.1 Microcarriers Market Revenue (US$ Mn), 2022 – 2030
6. Middle East & Africa Microcarriers Market – Revenue and Forecast to 2030 – by Product
6.1 Overview
6.2 Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Microcarrier Beads
6.3.1 Overview
6.3.2 Microcarrier Beads: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Media and Reagents
6.4.1 Overview
6.4.2 Media and Reagents: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Microcarriers Market – Revenue and Forecast to 2030 – by Equipment
7.1 Overview
7.2 Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
7.3 Bioreactors
7.3.1 Overview
7.3.2 Bioreactors: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Culture Vessels
7.4.1 Overview
7.4.2 Culture Vessels: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Microcarriers Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Biopharmaceutical Production
8.3.1 Overview
8.3.2 Biopharmaceutical Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8.3.3 Therapeutic Protein Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8.3.4 Vaccine Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Cell and Gene Therapy
8.4.1 Overview
8.4.2 Cell and Gene Therapy: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Tissue Engineering and Regenerative Medicine
8.5.1 Overview
8.5.2 Tissue Engineering and Regenerative Medicine: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Microcarriers Market Revenue and Forecasts To 2030 – End User
9.1 Overview
9.2 Middle East & Africa Microcarriers Market Share by End User – 2022 & 2030 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies: Microcarriers Market- Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Research Organizations and Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)
10. Middle East & Africa Microcarriers Market Revenue and Forecasts to 2030 – Country Analysis
10.1 Middle East & Africa Microcarriers Market, Revenue and Forecast To 2030
10.1.1 Overview
10.1.2 Middle East & Africa: Microcarriers Market, by Country
10.1.2.1 Saudi Arabia
10.1.2.1.1 Overview
10.1.2.1.2 Saudi Arabia: Microcarriers Market Revenue and Forecast to 2030 (SAUDI ARABIA$ Mn)
10.1.2.1.3 Saudi Arabia: Microcarriers Market, by Product
10.1.2.1.4 Saudi Arabia: Microcarriers Market, by Equipment
10.1.2.1.5 Saudi Arabia: Microcarriers Market, by Application
10.1.2.1.5.1 Saudi Arabia: Microcarriers Market, by Biopharmaceutical Production
10.1.2.1.6 Saudi Arabia: Microcarriers Market, by End User
10.1.2.2 South Africa
10.1.2.2.1 Overview
10.1.2.2.2 South Africa: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.3 South Africa: Microcarriers Market, by Product
10.1.2.2.4 South Africa: Microcarriers Market, by Equipment
10.1.2.2.5 South Africa: Microcarriers Market, by Application
10.1.2.2.5.1 South Africa: Microcarriers Market, by Biopharmaceutical Production
10.1.2.2.6 South Africa: Microcarriers Market, by End User
10.1.2.3 UAE
10.1.2.3.1 Overview
10.1.2.3.2 UAE: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.3.3 UAE: Microcarriers Market, by Product
10.1.2.3.4 UAE: Microcarriers Market, by Equipment
10.1.2.3.5 UAE: Microcarriers Market, by Application
10.1.2.3.5.1 UAE: Microcarriers Market, by Biopharmaceutical Production
10.1.2.3.6 UAE: Microcarriers Market, by End User
10.1.2.4 Rest Middle East & Africa
10.1.2.4.1 Overview
10.1.2.4.2 Rest Middle East & Africa: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
10.1.2.4.3 Rest Middle East & Africa: Microcarriers Market, by Product
10.1.2.4.4 Rest Middle East & Africa: Microcarriers Market, by Equipment
10.1.2.4.5 Rest Middle East & Africa: Microcarriers Market, by Application
10.1.2.4.5.1 Rest Middle East & Africa: Microcarriers Market, by Biopharmaceutical Production
10.1.2.4.6 Rest Middle East & Africa: Microcarriers Market, by End User
11. Microcarriers Market-Industry Landscape
11.1 Overview
11.2 Organic Growth Strategies
11.2.1 Overview
11.3 Inorganic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Bio-Rad Laboratories Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Sartorius AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Danaher Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Eppendorf SE
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Asahi Kasei Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Polysciences Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About the Research Team
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Microcarriers Market Segmentation
Table 2. Saudi Arabia Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 3. Saudi Arabia Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 4. Saudi Arabia Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 5. Saudi Arabia Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 6. Saudi Arabia: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 7. South Africa Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 8. South Africa Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 9. South Africa Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 10. South Africa Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 11. South Africa: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 12. UAE Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 13. UAE Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 14. UAE Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 15. UAE Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 16. UAE: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 17. Rest Middle East & Africa Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 18. Rest Middle East & Africa Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 19. Rest Middle East & Africa Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 20. Rest Middle East & Africa Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 21. Rest Middle East & Africa: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 22. Recent Organic Growth Strategies in Microcarriers Market
Table 23. Recent Inorganic Growth Strategies in the Microcarriers Market
Table 24. Glossary of Terms
Â
LIST OF FIGURES
Figure 1. Microcarriers Market Segmentation, By Country
Figure 2. Key Insights
Figure 3. Microcarriers Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints for Microcarriers Market
Figure 5. Microcarriers Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
Figure 7. Microcarrier Beads: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Media and Reagents: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 10. Bioreactors: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Culture Vessels: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
Figure 14. Biopharmaceutical Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Therapeutic Protein Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Vaccine Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Cell and Gene Therapy: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Tissue Engineering and Regenerative Medicine: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Middle East & Africa Microcarriers Market Share by End User – 2022 & 2030 (%)
Figure 21. Pharmaceutical and Biotechnology Companies: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
Figure 22. Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
Figure 23. Academic and Research Institutes: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
Figure 24. Microcarriers Market, 2022 (US$Mn)
Figure 25. Middle East & Africa: Microcarriers Market, By Countries, 2022 And 2030 (%)
Figure 26. Saudi Arabia: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. South Africa: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. UAE: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Rest Middle East & Africa: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
The List of Companies – Middle East & Africa Microcarriers Market
1. Bio-Rad Laboratories Inc
2. Sartorius AG
3. Danaher Corp
4. Eppendorf SE
5. Asahi Kasei Corp
6. Polysciences Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.